Pangea Biomed
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- CMO, CRO
Pangea has developed the ENLIGHT platform, based on over 10 years of academic research led by Prof. Eytan Ruppin (now Chief of the Cancer Science Data Lab at the U.S. NCI). ENLIGHT predicts response to treatment for a wide variety of indications and therapies based on analysis of either RNAseq data (ENLIGHT-NGS) or histopathology slide images from a tumor biopsy (ENLIGHT-DP).
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}